Company Overview and News

 
Capitaland 'outperform', Sime Darby 'add', Wah Seong 'neutral', Berjaya Sports Toto 'buy'

2018-03-20 thestar.com.my
CapitaLand Malaysia Mall Trust (CMMT)’s share price has declined 30% year-to-date and is below the initial public offering (IPO) price of RM1.08 (in 2010).

 
Trading ideas: MWE, BToto, Wah Seong, Vizione

2018-03-19 thestar.com.my
KUALA LUMPUR: MWE Holdings Bhd , Berjaya Sports Toto Bhd , Wah Seong Corp BHd and Vizione Holdings Bhd are among the stocks to watch on Monday, according to JF Apex Research.

 
Sports Toto posts 23% hike in profit

2018-03-17 thestar.com.my
KUALA LUMPUR: Berjaya Sports Toto Bhd says “rampant” illegal gambling is a challenge for the company, even as it posted a 23% jump in net profit to RM59.2mil in the third quarter ended Jan 31.

 
BToto warns rampant illegal gambling may hurt earnings

2018-03-16 thestar.com.my
KUALA LUMPUR: Berjaya Sports Toto Bhd says “rampant” illegal gambling is a challenge for the company, even as it posted a 23% jump in net profit to RM59.2mil in the third quarter ended Jan 31.

1
Malaysia’s top 40 richest people

2018-02-03 thestar.com.my
LAST year was dotted by the return of higher commodity prices and better economic growth. The world’s economies on average are back in business as growth rates and trade have started to improve once again after some period of uncertainty caused by a cooling China economy and also the slump in global crude oil prices.

 
BToto director Dickson Tan retires

2017-10-11 thestar.com.my
Tags / Keywords: Corporate News , Berjaya Sports Toto Bhd , Datuk Dickson Tan Yong Loong

 
Eye on stock: Berjaya Sports Toto

2017-09-22 thestar.com.my
BERJAYA Sports Toto Bhd (BJToto; Code: 1562) shares slumped to a low of RM2.25 in late August, the worst level since May 2003, dragged down by persistent profit-taking liquidation pressure. At that moment, prices looked frail and defenceless. Hence, prices risked sustaining the downward spiral and appeared in great danger of slipping below RM2.06-RM2.10 concrete floor, going forward.

 
BJToto 'buy', Hai-O 'buy', Spritzer 'market perform'

2017-09-22 thestar.com.my
The company’s first quarter FY18’s core net profit of RM71.2mil (+3% year-on-year (yoy), +2% quarter-on-quarter) was within its expectations at 23% of its full year estimates.

 
Trading ideas: BToto, Hai-O, Lotte Chemical, Econpile

2017-09-21 thestar.com.my
KUALA LUMPUR: Berjaya Sports Toto Bhd , Hai-O Enterprise Bhd , Lotte Chemical, Econpile and PPB Group are among the stocks to watch on Thursday, according to JF Apex Research.

 
Breakfast briefing: Thursday, September 21

2017-09-21 thestar.com.my
MarketWatch: The S&P 500 and the Dow ended slightly higher on Wednesday, adding to their string of closing records, after the Federal Reserve signalled it expects another interest rate hike by year-end and disclosed timing for reducing its balance sheet. The DJIA rose 41.79 points, or 0.19% to end at 22,412.59, its seventh straight record close. The S&P 500 gained 1.59 points, or 0.06%, to 2,508.24, clocking its sixth record closing high in the last seven sessions.

 
Berjaya Sports Toto Q1 earnings jump to RM74mil

2017-09-21 thestar.com.my
The number forecast operator (NFO) attributed the higher revenue and net profit for the period ended July 31, 2017, to improved performance by 98.38% indirect-owned UK automobile distributor HR Owen Plc and foreign exchange gains recognised by a foreign subsidiary company.

 
Bursa 'hold', Top Glove 'hold', BToto 'buy'

2017-07-20 thestar.com.my
AFFIN Hwang Capital Research has downgraded Bursa Malaysia Bhd to Hold from Buy on valuation grounds, following the counter’s share price outperformance.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

7h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

8h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

18h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...